Summary
Four preparations of Bacillus Calmette-Guérin (BCG), cultured either homogeneously dispersed or as a surface pellicle, were compared with reference to their immunomodulating capacities and antitumor effects. The BCG preparations included two vaccines that originated from the same seed strain, but one had subsequently been produced in each way. The immunological assays included in vivo stimulation of lymph nodes in a mouse model, in vitro stimulation of murine spleen lymphocytes, and in vivo stimulation of macrophages in a Listeria monocytogenes clearance model in the mouse. The antitumor effect was determined in a non-immunogenic, non-metastasizing murine fibrosarcoma. The results indicated that vaccines produced as a homogeneous culture in general induced a higher lymphocyte stimulation both in vivo and in vitro. In the Listeria clearance model a markedly enhanced clearance was established with three of the four preparations, the phenomenon being related to the number of culturable particles administered. This difference was not attributed to the production method, but to other factors, including the actual composition of the vaccine.
The results found in the immunological assays were not connected to the observed antitumor activities, as for each preparation a combination of route, dose, and time interval for tumor regression was found. Prophylactic administration of BCG had no effect at all; enhancement was observed after intratumoral administration of the two preparations prepared as surface pellicles.
It is concluded that a protocol for the quality control of bacterial vaccines used for cancer immunotherapy should include both immunological assays and a range of different animal tumor models.
Similar content being viewed by others
References
Bast RC Jr, Bast BS, Rapp HJ (1976) Clinical review of previously reported animal studies of tumor immunotherapy with nonspecific immunostimulants. Ann NY Acad Sci 277:60
Bonta JL, Noordhoek J (1973) Anti-inflammatory mechanism of inflammed tissue factor. Agents Actions 3:348
Bruynzeel DP, Ettekoven H, Kreeftenberg JG (1978a) Proposals for quality control methods of bacterial vaccines for immunostimulation. II. In vivo and in vitro stimulation of lymphocytes by BCG. Dev Biol Stand 38:91
Bruynzeel DP, Ettekoven H, Kreeftenberg JG (1978b) The synergistic activity of BCG on the stimulation of lymphocytes with Concanavalin A and Lipopolysaccharide. Cancer Immunol Immunother 3:253
Halle-Pannenko O, Bourut C, Kamel M (1976) Comparison of various BCG preparations in the EORTC — ICIG experimental screening for systemic immunity adjuvants applicable to cancer immunotherapy. Cancer Immunol Immunother 1:17
Hemert PA van (1973) Vaccine production as a unit process. Thesis, Delft
Lagrange PH, Miller TE, Mackaness GB (1976) Parameters conditioning the potentiating effect of BCG on the immune response. In: Hamoureux G, Turcotte R, Portelance V (eds) BCG in cancer immunotherapy. Grune & Stratton, New York, p 23
Lane FC, Unanue ER (1972) Requirements of thymus (T) lymphocytes for resistance to listeriosis. J Exp Med 135:1104
Mackaness GB (1969) The influence of immunologically committed lymphoid cells on macrophage activity in vivo. J Exp Med 129:873
Mackaness GB, Auclair DJ, Lagrange PH (1973) Immunopotentiation with BCG. I. Immune response to different strains and preparations. J Natl Cancer Inst 51:1655
Mathé G (1978) Editorial: Systemic active immunotherapy is shifting from the middle ages to a renaissance period. Cancer Immunol Immunother 5:149
Rapp HJ (1977) Guest editorial: Of cavies and men: the propriety and rationality of “Cancer Immunotherapy”. J Natl Cancer Inst 59:1577
Ruitenberg EJ, Noorle Jansen LM van, Kruizinga W, Steerenberg PA (1976) Effect of pretreatment with Bacillus Calmette-Guérin on the course of a Listeria monocytogenes infection in normal and congenitally athymic (nude) mice. Br J Exp Pathol 57:310
Ruitenberg EJ, Steerenberg PA, Noorle Jansen LM van (1978) Proposals for quality control methods of bacterial vaccines for immunostimulation. III. Effect of BCG and C. parvum on in vivo Listeria clearance and tumor growth. Dev Biol Stand 38:97
Ruitenberg EJ, Sirks JL, Kreeftenberg JG, Steerenberg PA (1980) The use and evaluation of bacterial vaccines in immunotherapy of cancer. In: van Miert ASJPAM, Frens J, van der Kreek FW (eds) Proceedings of the First European Congress on Veterinary Pharmacology and Toxicology. Elsevier, Amsterdam, p 97
Sirks JL, Ruitenberg EJ (1978) Proposals for quality control methods of bacterial vaccines for immunostimulation. I. General considerations. Dev Biol Stand 38:87
Sirks JL, Cohen HH, Smith L (1971) Production of freeze-dried BCG-vaccine. Symposia Series in Immunobiological Standardization 17:163
Author information
Authors and Affiliations
Additional information
Fellow of the Koningin Wilhelmina Fonds of the National Cancer League of the Netherlands
The Abbreviations used are: BCG, Bacillus Calmette-Guérine; c.p., culturable particles; Con A, Concanavalin A; MEM, Minimum Essential Medium; FCS, fetal calf serum; cpm, counts per minute; IT, intratumoral
Rights and permissions
About this article
Cite this article
Ruitenberg, E.J., de Jong, W.H., Kreeftenberg, J.G. et al. BCG preparations, cultured homogeneously dispersed or as a surface pellicle, elicit different immunopotentiating effects but have similar antitumor activity in a murine fibrosarcoma. Cancer Immunol Immunother 11, 45–51 (1981). https://doi.org/10.1007/BF00205773
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00205773